CRS CRS Clinical Research Regulations 2

Question 1

Phase I clinical trials primarily assess which of the following?

Accepted Answer

Safety, tolerability, and dosage

Answer

Phase I trials focus on evaluating the safety, tolerability, and appropriate dosing of a new intervention in a small group of participants.

Question 2

What does 21 CFR Part 11 regulate in the context of clinical research?

Accepted Answer

Electronic records and electronic signatures

Answer

21 CFR Part 11 sets FDA requirements for the use of electronic records and electronic signatures in regulated clinical studies.

Question 3

An unexpected, fatal serious adverse event (SAE) in a clinical trial must be reported to the FDA within how many calendar days?

Accepted Answer

7 days

Answer

Unexpected fatal or life-threatening serious adverse events must be reported to the FDA within 7 calendar days of the sponsor's knowledge.

Question 4

Which document outlines the objectives, design, methodology, and statistical considerations of a clinical trial?

Accepted Answer

Study Protocol

Answer

The study protocol is the master document that describes the scientific rationale, objectives, and procedures for conducting a clinical trial.

Question 5

What is the role of a Sponsor in a clinical trial as defined by federal regulations?

Accepted Answer

To take responsibility for initiating, managing, and financing the trial

Answer

The Sponsor is the entity that initiates, manages, and bears overall responsibility for the design, conduct, and regulatory compliance of a clinical trial.

(CRS) Certified Research Specialist Practice Test

(CRS) Certified Research Specialist Practice Test

CRS CRS Clinical Research Regulations 2